Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

February 2012 - FRMC

Vemurafenib Accelerates Secondary Skin Cancer in Some Patients
02/22/2012
Although vemurafenib improves outcomes in patients with advanced melanoma that harbors a BRAF gene mutation, the drug also accelerates the development of squamous-cell carcinomas and keratoacanthomas in some patients. Results that show a skin...
Although vemurafenib improves outcomes in patients with advanced melanoma that harbors a BRAF gene mutation, the drug also accelerates the development of squamous-cell carcinomas and keratoacanthomas in some patients. Results that show a skin...
Although vemurafenib improves...
02/22/2012
First Report Managed Care
HPV Vaccination among Teens
02/22/2012
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection (STI) in the United States. HPV has a prevalence of 29.5% in sexually experienced girls 14 to 19 years of age. Sequelae of HPV infection may include genital...
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection (STI) in the United States. HPV has a prevalence of 29.5% in sexually experienced girls 14 to 19 years of age. Sequelae of HPV infection may include genital...
Human papillomavirus (HPV) is...
02/22/2012
First Report Managed Care
Treating Osteoporosis in Postmenopausal Women
02/22/2012
New Orleans—According to an analysis of clinical trials, bazedoxifene is effective as a second-line therapy for postmenopausal women who have osteoporosis, although the drug is not cost-effective compared with raloxifene. Bazedoxifene and...
New Orleans—According to an analysis of clinical trials, bazedoxifene is effective as a second-line therapy for postmenopausal women who have osteoporosis, although the drug is not cost-effective compared with raloxifene. Bazedoxifene and...
New Orleans—According to an...
02/22/2012
First Report Managed Care
Cost Comparison of Fulvestrant Regimens
02/22/2012
A study comparing the cost of fulvestrant found that 250 mg appears to be a cost-effective option in treating postmenopausal women with breast cancer.
A study comparing the cost of fulvestrant found that 250 mg appears to be a cost-effective option in treating postmenopausal women with breast cancer.
A study comparing the cost of...
02/22/2012
First Report Managed Care
Length of Hospital Stay Associated with Dabigatran and Warfarin
02/22/2012
New Orleans—A retrospective cohort study found that patients with atrial fibrillation (AF) who took dabigatran did not have a significant reduction in length of stay in a hospital compared with those who took warfarin. However, the authors...
New Orleans—A retrospective cohort study found that patients with atrial fibrillation (AF) who took dabigatran did not have a significant reduction in length of stay in a hospital compared with those who took warfarin. However, the authors...
New Orleans—A retrospective...
02/22/2012
First Report Managed Care
Cost-Effectiveness and Survival of HRPC Treatments
02/22/2012
To determine survival benefits for patients with hormone-refractory prostate cancer, researchers looked at treating HRPC with sipuleucel-T and docetaxel.
To determine survival benefits for patients with hormone-refractory prostate cancer, researchers looked at treating HRPC with sipuleucel-T and docetaxel.
To determine survival benefits...
02/22/2012
First Report Managed Care
TNF Antagonists and Cardiovascular Disease Risk
02/22/2012
Chicago—Data from a large epidemiologic study presented at the ACR meeting suggest a trend toward reduced cardiovascular disease (CVD) risk among patients with rheumatoid arthritis (RA) during the first 6 months of initiating treatment with...
Chicago—Data from a large epidemiologic study presented at the ACR meeting suggest a trend toward reduced cardiovascular disease (CVD) risk among patients with rheumatoid arthritis (RA) during the first 6 months of initiating treatment with...
Chicago—Data from a large...
02/22/2012
First Report Managed Care

Department

News Connection
Genital Herpes Vaccine Only Protects against One Strain of Virus
02/22/2012
A vaccine for genital herpes was effective in protecting some women from genital disease and infection from herpes simplex type 1 but not from type 2.
A vaccine for genital herpes was effective in protecting some women from genital disease and infection from herpes simplex type 1 but not from type 2.
A vaccine for genital herpes was...
02/22/2012
First Report Managed Care
Conference Insider
Serious Infections in Patients with Autoimmune Diseases
02/22/2012
Chicago—The risk of serious infection was not significantly increased in patients with autoimmune diseases initiating treatment with tumor necrosis factor (TNF) antagonists compared with those treated with nonbiologic disease regimens, even...
Chicago—The risk of serious infection was not significantly increased in patients with autoimmune diseases initiating treatment with tumor necrosis factor (TNF) antagonists compared with those treated with nonbiologic disease regimens, even...
Chicago—The risk of serious...
02/22/2012
First Report Managed Care
Conference Insider
Anti-TNF Therapy and Solid Cancer Risk
02/22/2012
Chicago—Patients treated with anti–tumor necrosis factor (TNF) therapy for rheumatoid arthritis (RA) are not at increased risk of solid cancers compared with patients receiving nonbiologic disease-modifying antirheumatic drugs (DMARDs),...
Chicago—Patients treated with anti–tumor necrosis factor (TNF) therapy for rheumatoid arthritis (RA) are not at increased risk of solid cancers compared with patients receiving nonbiologic disease-modifying antirheumatic drugs (DMARDs),...
Chicago—Patients treated with...
02/22/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Starting Specific Biologics Linked With Greater Asthma Burden
05/23/2019
“Real-world data on the characteristics and burden of disease among patients with asthma before receiving asthma-specific biologics would improve the understanding of the use of these therapies in a clinical setting,” researchers wrote.
“Real-world data on the characteristics and burden of disease among patients with asthma before receiving asthma-specific biologics would improve the understanding of the use of these therapies in a clinical setting,” researchers wrote.
“Real-world data on the...
05/23/2019
First Report Managed Care
News
Dems launch $2M pro-reform blitz
09/07/2010
09/07/2010
First Report Managed Care
Oncology Care Model: Delivering Better Care
09/15/2017
The CMS Oncology Care Model turned 1 year old this July.
The CMS Oncology Care Model turned 1 year old this July.
The CMS Oncology Care Model...
09/15/2017
First Report Managed Care
News
Access to Widen on Medicare Data
01/29/2012
01/29/2012
First Report Managed Care
News
Real-World Examples of Benefit Integration Management
03/31/2015
San Diego—During a session at the AMCP meeting, Jennifer Schauer, PharmD, clinical pharmacist, University of Wisconsin Hospital & Clinics, Unity Health Insurance, Madison, Wisconsin, and Elizabeth Kelly, PharmD, clinical manager, pharmacy...
San Diego—During a session at the AMCP meeting, Jennifer Schauer, PharmD, clinical pharmacist, University of Wisconsin Hospital & Clinics, Unity Health Insurance, Madison, Wisconsin, and Elizabeth Kelly, PharmD, clinical manager, pharmacy...
San Diego—During a session at...
03/31/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

February 2012 Volume 9 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement